Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

Share Price is delayed by 15 minutes
Get Live Data
14,318.00    0.00 (0.00%)
Bid:
13,100.00
Ask:
15,000.00
Spread: 1,900.00 (14.504%)
Market Cap: £222.05b
AZN Live PriceLast checked at - London Stock Exchange

Intraday Astrazeneca Share Chart

Astrazeneca News

Pharma industry says UK pricing revenue unsustainable, blocking investments
20 Mar 2025

Pharma industry says UK pricing revenue unsustainable, blocking investments

LONDON, March 20 (Reuters) - The pharmaceutical industry on Thursday blasted the UK government's levy that aims to curb the national health system's...

Foreign CEOs to flock to China for key summit, Xi meeting, sources say
17 Mar 2025

Foreign CEOs to flock to China for key summit, Xi meeting, sources say

BEIJING, March 17 (Reuters) - Dozens of foreign CEOs will visit Beijing this month for a flagship development conference where some are expected to ...

AstraZeneca boosts cancer therapies push with $1 billion EsoBiotec buy
17 Mar 2025

AstraZeneca boosts cancer therapies push with $1 billion EsoBiotec buy

AstraZeneca to buy EsoBiotec for up to $1 billion *

AstraZeneca to pay up to USD1 billion for cell therapy firm, EsoBiotec
17 Mar 2025

AstraZeneca to pay up to USD1 billion for cell therapy firm, EsoBiotec

(Alliance News) - AstraZeneca PLC on Monday announced an acquisition, a license agreement, regulatory approval in Europe for cancer drug Imfinzi, and ...

LONDON BRIEFING: Phoenix Group "ahead of plan"; AstraZeneca makes buy
17 Mar 2025

LONDON BRIEFING: Phoenix Group "ahead of plan"; AstraZeneca makes buy

(Alliance News) - Stocks in London are called to open flat on Monday, as investors digest plans by Chinese officials to boost consumption there, befor...

AstraZeneca buys biotech firm Esobiotec for up to $1bn
17 Mar 2025

AstraZeneca buys biotech firm Esobiotec for up to $1bn

(Sharecast News) - AstraZeneca announced on Monday that it is spending up to $1bn to acquire Belgian biotech firm EsoBiotec, which it says has the pot...

Roche secures Zealand obesity drug candidate for up to $5.3 billion
12 Mar 2025

Roche secures Zealand obesity drug candidate for up to $5.3 billion

Deal signals renewed efforts by Roche to compete on obesity *